Strasbaugh Receives Order from Japanese customer for nTrepid CMP System

Strasbaugh (OTC Bulletin Board: STRB.OB) announced today that it has received its first order from a Japanese customer for the company's nTrepid CMP system. The machine is upgraded with Strasbaugh's newly-released STB P300 CMP technologies.

"This order is a strategic win for Strasbaugh. It will be the first placement of the newest configuration of the nTrepid CMP platform in the important Japanese market. It demonstrates the competitiveness of our tool internationally," said Chuck Schillings, Strasbaugh's President and CEO.

The nTrepid is a high volume CMP system, offering superior process performance, unmatched small-lot and high-mix production flexibility, and low cost of ownership. It is now available with the latest CMP technologies recently released with Strasbaugh's new STB P300 CMP system. The new technologies include revolutionary optical endpoint detection capability, next generation wafer carriers, ultra precise pad conditioning, and industry-proven integrated cleaning.

TPS System Co., Ltd., Strasbaugh's sales representative in Japan, secured the order and will assist in providing service and technical support for the customer.

Strasbaugh has 60 years of leadership in design and manufacturing of advanced surfacing technology for the global semiconductor, silicon, data storage, MEMS, LED, telecommunications and optics industries. Through close alliances with premier manufacturers in these markets, Strasbaugh has developed pioneering technology that has become the standard in polishing and grinding today. Strasbaugh's state-of-the-art chemical mechanical planarization (CMP) systems, high quality prime wafer polishing and grinding tools, and leading edge process technologies, enable customers to realize their performance goals and has established the company as a world class provider of innovative, reliable, high-yield surfacing solutions.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.